BamSEC and AlphaSense Join Forces
Learn More

Achieve Life Sciences Inc.

NASDAQ: ACHV    
Share price (12/20/24): $3.69    
Market cap (12/20/24): $127 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 4 pages Third Amended and Restated Certificate of Incorporation of Achieve Life Sciences, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Achieve Life Sciences, Inc
12/34/56
EX-3.1
from 8-K 21 pages Achieve Life Sciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.12
from S-1/A 21 pages Achieve Life Sciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3
from SC 13G 1 page Adamas Capital Management (CY) Limited (The “Company”) Unanimous Written Resolution of the Directors of the Company Dated May 27, 2019
12/34/56
EX-3.1
from 10-Q 1 page Amendment to Sixth Amended and Restated Bylaws of Achieve Life Sciences
12/34/56
EX-3.1
from 8-K 21 pages Achieve Life Sciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3
from S-1/A 20 pages Achieve Life Sciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Achieve Life Sciences, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Achieve Life Sciences, Inc
12/34/56
EX-3.1
from 8-K 1 page Achieve Life Sciences, Inc. Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 13 pages Sixth Amended and Restated Bylaws of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.1
from 425 13 pages Sixth Amended and Restated Bylaws of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Oncogenex Pharmaceuticals, Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 5 pages Second Amended and Restated Certificate of Incorporation of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 11 pages Fifth Amended and Restated Bylaws of Oncogenex Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Oncogenex Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.1
from 8-K 13 pages Fourth Amended and Restated Bylaws of Oncogenex Pharmaceuticals, Inc
12/34/56